BU-NOT-SET

CONTACT US
Getting on track with FMD
  • Manufacturing
Eyes
Insight
The advantages of modified release oral dosage forms
  • Drug product
Eyes
Insight
Streamlining scale-up for drug substances
  • Drug substance
Filling
Insight
Oral solids endure and evolve
  • Drug product
Eyes
Insight
Patient-centric drug development comes of age
  • Drug product
Eyes
Insight
Looking beyond the deadline
  • Manufacturing
Eyes
Insight
Modified release formulations: improving efficacy and patient compliance
  • Drug product
Eyes
Insight
FMD: industry thoughts as serialisation deadline nears
  • Manufacturing
Eyes
Insight
Sustainability report 2019
  • Sustainability
Report
Report
Insight
  • Drug substance
The oncolytic efficacy and in vivo pharmacokinetics of [2-(4- Chlorophenyl)quinolin-4-yl](piperidine-2-yl)methanol (Vacquinol-1) are governed by distinct stereochemical features
Insight
  • Manufacturing
Strategies to prepare for serialisation
Insight
  • Drug substance
A Versatile One-Pot Procedure for the Synthesis of 5-Aryl-6H- 1,3,4-thiadiazine-2-amines from Aromatic Ketones